BD Board Declares Dividend: Feb 1, 2011

Feb 02, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson's board of directors has declared a quarterly dividend of $.41.

The dividend is payable on March 31 to holders of record on March 10.

The firm said its indicated annual dividend rate is $1.64.

Filed under

dividend

Becton Dickinson

Breaking News

Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies
Lucira Health Combo Flu/COVID-19 MDx Test Gets Regulatory Approval in Australia
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech
Burning Rock Q4 Revenues Down 4 Percent Due to COVID-19 Resurgence in China
Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.